FDA Drugs (New Approvals & NDA)Original article
Emergency Use Authorizations for Drugs and Non-Vaccine Biological Products
RegulatoryrejectedNegative
AI Analysis
Summary
The HHS Secretary terminated Emergency Use Authorizations for COVID-19 drugs and biological products, determining that circumstances no longer justify their emergency authorization during the pandemic.
Outcome Details
Emergency Use Authorizations for COVID-19 drugs and biological products terminated
Importance:7/10
Sentiment:
-0.70
COVID-19EUAEmergency Use Authorizationregulatory actiontermination
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 1, 2026 9:50 PM